Mass General Brigham’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,464	Closed	-$1.05M	–	8
2021 Q2	$1.05M	Buy	+6,464	New	+$1.05M	0.26%	7